US Stock MarketDetailed Quotes

Cogent Biosciences (COGT)

Watchlist
  • 34.290
  • -0.240-0.70%
Close May 13 16:00 ET
5.86BMarket Cap-15.80P/E (TTM)

Cogent Biosciences (COGT) Revenue Breakdown Overview

By Business/Source

Currency:USD
2020/FY
Stock NameRevenueRatio
Development and commercialization of precision therapies for genetically defined diseases7.87M100.00%

By Country/Region

Currency:USD
2020/FY
Stock NameRevenueRatio
United States7.87M100.00%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More